BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9445414)

  • 1. Pulmonary hypertension--beyond vasodilator therapy.
    Fishman AP
    N Engl J Med; 1998 Jan; 338(5):321-2. PubMed ID: 9445414
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV; Genthner DE; Panella MM; Rich S
    N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    Botney M
    N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension.
    Benvenuto DB
    J Intraven Nurs; 1999; 22(5):267-72. PubMed ID: 10776190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous epoprostenol for primary pulmonary hypertension.
    Schulze-Neick I; Lange PE; Haas NA
    N Engl J Med; 1996 May; 334(22):1477; author reply 1477-8. PubMed ID: 8618596
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.
    Oikawa M; Kagaya Y; Otani H; Sakuma M; Demachi J; Suzuki J; Takahashi T; Nawata J; Ido T; Watanabe J; Shirato K
    J Am Coll Cardiol; 2005 Jun; 45(11):1849-55. PubMed ID: 15936618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
    Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
    Sabo JA; Nord CP
    Crit Care Nurse; 2000 Dec; 20(6):31-40. PubMed ID: 11878257
    [No Abstract]   [Full Text] [Related]  

  • 10. Epoprostenol therapy for primary pulmonary hypertension.
    Cheever KH; Kitzes B; Genthner D
    Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
    Kato H; Katori T; Nakamura Y; Kawarasaki H
    Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension update.
    Hesselgrave B
    Case Manager; 2005; 16(6):61-6; quiz 67. PubMed ID: 16326325
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary arterial hypertension: classification and therapy with a focus on prostaglandin analogs.
    Papierniak ES; Lowenthal DT; Mubarak K
    Am J Ther; 2012 Jul; 19(4):300-14. PubMed ID: 21642835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing patients with primary pulmonary hypertension: prostacyclin therapy.
    Albert NM; Hague K
    Am J Crit Care; 1997 Jul; 6(4):274-80. PubMed ID: 9215424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Education of patients treated with a continuous epoprostenol infusion for pulmonary hypertension].
    Marlier D
    Soins; 2006 May; (705 Suppl):S7-12. PubMed ID: 16771257
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous intravenous prostacyclin for advanced primary pulmonary hypertension.
    Archer-Chicko C
    Dimens Crit Care Nurs; 2000; 19(2):14-21. PubMed ID: 10876492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure.
    Miyaji K; Nagata N; Miyamoto T; Kitahori K
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):437-9. PubMed ID: 12579126
    [No Abstract]   [Full Text] [Related]  

  • 20. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
    Scelsi L; Ghio S; Campana C; D'Armini AM; Serio A; Klersy C; Piovella F; Viganò M; Tavazzi L
    Ital Heart J; 2004 Aug; 5(8):618-23. PubMed ID: 15554033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.